Krystal Biotech buy Citigroup Inc.
Start price
27.02.24
/
50%
€152.00
Target price
27.02.25
€179.60
Performance (%)
14.14%
End price
28.02.25
€173.50
Summary
This prediction ended on 28.02.25 with a price of €173.50. The BUY prediction by Citigroup_Inc_ finished with a performance of 14.14%. Citigroup_Inc_ has a follow-up prediction for Krystal Biotech where he still thinks Krystal Biotech is a Buy. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Krystal Biotech | -2.512% | -2.512% | 67.984% |
| iShares Core DAX® | -1.933% | 2.239% | 16.921% |
| iShares Nasdaq 100 | -0.972% | 0.226% | 5.003% |
| iShares Nikkei 225® | -2.056% | 5.685% | 19.218% |
| iShares S&P 500 | -1.185% | 0.867% | 2.378% |
Comments by Citigroup_Inc_ for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its price target raised by analysts at Citigroup Inc. from $160.00 to $195.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat
In the thread Trading Krystal Biotech
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten